What question did this study set out to answer?

The aim is to evaluate mean platelet volume (MPV) as a low-cost marker for thrombotic risk in Yemeni patients with type 2 diabetes mellitus (T2DM).

February 2, 2026Open Access

Mean platelet volume as a Low-Cost discriminatory marker for thrombotic risk assessment in Yemeni type 2 diabetic patients: A proposal for Resource-Limited settings

Key Points

The aim is to evaluate mean platelet volume (MPV) as a low-cost marker for thrombotic risk in Yemeni patients with type 2 diabetes mellitus (T2DM).
Assess MPV levels in Yemeni T2DM patients
Propose integration of MPV testing into diabetic guidelines
Evaluate cost-effectiveness in resource-limited settings
MPV ≥ 11.5 fL indicates high thrombotic risk
Routine MPV testing is low-cost
Potential for improved preventive care in Yemen and similar regions

Abstract

MPV ≥ 11.5 fL shows promise as a highly discriminatory, low-cost marker of thrombotic risk in Yemeni T2DM patients. We propose that routine MPV testing should be considered for integration into national diabetic guidelines in Yemen and similar conflict-affected settings. This evidence-based, low-cost strategy could contribute to improved preventive care and reduce the burden of thrombosis where resources are most scarce.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Ali et al. (Thu,) studied this question.

synapsesocial.com/papers/6980fc91c1c9540dea80e5c2 https://doi.org/https://doi.org/10.1186/s13031-026-00754-9

Bookmark

View Full Paper